Otwarty dostęp

Impact of AKT1 polymorphism on DNA damage, BTG2 expression, and risk of colorectal cancer development


Zacytuj

Figure 1

Akt rs1130233 single nucleotide polymorphism in (A) Control and (B) colorectal cancer patients. Representative images have been shown. AA genotype (379 bp band); AG genotype (245 and 379 bp bands); GG genotype (245 bp band). The number above the lanes indicate subjects identity.C = Control, P = CRC Patient, M = DNA Marker
Akt rs1130233 single nucleotide polymorphism in (A) Control and (B) colorectal cancer patients. Representative images have been shown. AA genotype (379 bp band); AG genotype (245 and 379 bp bands); GG genotype (245 bp band). The number above the lanes indicate subjects identity.C = Control, P = CRC Patient, M = DNA Marker

Figure 2

Association of AKT rs1130233 single nucleotide polymorphism with AKT expression and phosphorylation (A) Representative images of immunoblotting showing expression of AKT and pAKT in lymphocytes of GG, AG and AA carriers. (B) Mean densitometry profile of AKT and pAkt expression of different subjects of various genotypes. P < 0.05 GG vs AG, and P < 0.01 GG vs AA.
Association of AKT rs1130233 single nucleotide polymorphism with AKT expression and phosphorylation (A) Representative images of immunoblotting showing expression of AKT and pAKT in lymphocytes of GG, AG and AA carriers. (B) Mean densitometry profile of AKT and pAkt expression of different subjects of various genotypes. P < 0.05 GG vs AG, and P < 0.01 GG vs AA.

Figure 3

Association of AKT rs1130233 single nucleotide polymorphism BTG2 expression. Representative images have been shown. (A) BTG2 (360 bp) expression was determined in leukocytes of control individuals carrying GG, AG or AA genotypes of AKT1. GAPDH (158 bp) was used as a loading control. M = DNA Marker. (B) Mean densitometry profile of Btg2 mRNA expression of different subjects of various genotypes. P < 0.05 GG vs AG, and P < 0.01 GG vs AA.
Association of AKT rs1130233 single nucleotide polymorphism BTG2 expression. Representative images have been shown. (A) BTG2 (360 bp) expression was determined in leukocytes of control individuals carrying GG, AG or AA genotypes of AKT1. GAPDH (158 bp) was used as a loading control. M = DNA Marker. (B) Mean densitometry profile of Btg2 mRNA expression of different subjects of various genotypes. P < 0.05 GG vs AG, and P < 0.01 GG vs AA.

Figure 4

Association of AKT1 rs1130233 single nucleotide polymorphism with DNA damage. (A) Representative images of comet assay have been shown. (B) Comet tail was quantified in leukocytes of control individuals carrying GG, AG or AA genotypes of AKT1. P < 0.05 GG vs AG, and P < 0.01 GG vs AA.
Association of AKT1 rs1130233 single nucleotide polymorphism with DNA damage. (A) Representative images of comet assay have been shown. (B) Comet tail was quantified in leukocytes of control individuals carrying GG, AG or AA genotypes of AKT1. P < 0.05 GG vs AG, and P < 0.01 GG vs AA.

Frequencies of AKT1rs1130233 polymorphism and alleles in rectum cancer cases and control

Type of polymorphism Genotype n Rectum = 98 (%) n Control = 197 (%) P value OR (95% CI)
GG 30 (30.61) 90 (45.69) Reference
Genotype frequency AG 59 (60.20) 101 (51.27) 0.04 1.75 (1.04–2.96)
AA 9 (9.19) 6 (3.04) 0.008 4.50 (1.48–13.69)
Dominant model GG 30 (30.61) 90 (45.69) 0.01 1.91 (1.14–3.18)
AG+AA 68 (69.39) 107 (54.31)
Recessive model GG+AG 89 (90.81) 191 (96.96) 0.03 3.22 (1.11–9.32)
AA 9 (9.19) 6 (3.04)

Primers sequences and amplification conditions for genes

Genes Direction Primer sequence Amplification condition
BTG2 Forward 5/-CCTGGGCAGAGAGTGAAAAG-3/ 95°C for 5 min, followed by 30
Reverse 5/-CCTTCCATCCTAACCCCAAT-3/ cycles of 95°C for 30 s, 58°C for
Forward 5/-CCATGGAGAAGGCTGGGG-3/ 45 s, 72°C for 45 s and 72°C for
GAPDH Reverse 5/-CAAAGTTGTCATGGATGACC-3/ 10 min
Forward F1-5/-ATAGGGAGTCATGGAGGGTTTG-3/ 95°C for 5 min, followed by 35
AKT1 Reverse R1-5/-CTTTACCAAATCCTGGTCACTGAA-3/ cycles of 95°C for 30 s, 60°C for
Forward F2-5/-AAAAAATTGATTGATGGGAGGAAG-3/ 45 s, 72°C for 45 s and 72°C for
Reverse R2-5/-TAATCCCTGGCCTGCTCAG-3/ 10 min

Frequencies of AKT1 rs1130233 polymorphism and alleles in colon cancer cases and control

Type of polymorphism Genotype n = Colon 102 (%) n Control = 197 (%) P value OR (95% CI)
GG 30 (29.41) 90 (45.69) Reference
Genotype frequency AG 61 (59.80) 101 (51.27) 0.02 1.81 (1.08–3.05)
AA 11 (10.79) 6 (3.04) 0.001 5.50 (1.87–16.15)
Dominant model GG 30 (29.41) 90 (45.69) 0.006 2.02 (1.21–3.36)
AG+AA 72 (70.59) 107 (54.31)
Recessive model GG+AG 91 (89.21) 191 (96.96) 0.01 3.85 (1.38–10.73)
AA 11 (10.79) 6 (3.04)

Demographic and clinical information of control subjects and colorectal cancer patients

Characteristics Cases n = 200(%) Control n = 197(%)
Age*
           40 ≤ 131 (65.5) 120 (60.91)
           40 > 69 (34.5) 77 (39.09)
Sex*
           Male 119 (59.50) 112 (57.50)
           Female 81 (40.50) 85 (42.50)
Food consumption*
           Mainly vegetables 106 (53.00) 97 (49.24)
           Mixed Food 94 (47) 100 (50.76)
Smoking*
           Ever 36 (18.00%) 29 (14.72%)
           Never 164 (82.00%) 168 (85.28%)
Cancer family history*
           Yes 27 (13.50) 17 (8.63)
           No 173 (86.50) 180 (91.37)
Cancer Stages
           I 1 (0.50)
           II 33 (16.50)
           III 112 (56.00)
           IV 54 (27.00)

Gene and allele frequencies of AKT1 rs1130233 polymorphism and its association with colorectal cancer

Type of polymorphism Genotype n = Cases 200 (%) n Control = 197 (%) P value OR (95% CI)
GG 60 (30.00) 90 (45.69) Reference
Genotype Frequency AG 120 (60.00) 101 (51.27) 0.01 1.80 (1.18–2.74)
AA 20 (10.00) 6 (3.04) 0.001 5.00 (1.90–13.18)
Dominant Model GG 60 (30.00) 90 (45.69)
AG+AA 140 (70.00) 107 (54.31) 0.001 1.96 (1.30–2.96)
Recessive Model GG+AG 180 (90.00) 191 (96.96)
AA 20 (10.00) 6 (3.04) 0.01 0.28 (0.11–0.72)
Allele Frequency G A 0.6000 0.4000 0.7132 0.2868
eISSN:
1581-3207
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology